Altered glycosylation of glycolipids, glycoproteins, or proteoglycans are frequently observed in tumor tissues and cultured cancer cell lines. These changes have diagnostic use but also can contribute to the ability of tumor cells to grow, induce neovascularization, metastasize, and avoid host immune surveillance. We are primarily studying sulfated and sialylated glycoconjugates and their interaction with extracellular matrix and cell surface adhesion molecules, including thrombospondins. We previous demonstrated that heparan sulfate proteoglycans mediate inhibitory activities of thrombospondin-1 for T cell activation and proliferation as well as upstream modulation of Ras and MAP kinase signaling. We are isolating the proteoglycans that mediate these activities from T cells and examining the specificity of thrombospondin-1 for binding to proteoglycans required for signaling by angiogenic growth factors. Using metabolic labeling, we have demonstrated that T cells express several proteoglycans and release them into the medium. A 200 kDa secreted proteoglycan was identified that binds to TSP1. Inhibitors of these interactions are being tested for effects on angiogenesis and tumor growth. Although TSP1 clearly affects functional responses of mature immune cells, its role in development of the immune system has not been studied. We compared the cellular composition of various lymphoid organs in adult wild type and TSP1 null mice and found that maturation of T cell subsets appeared to be normal in thymus of TSP1 mutant mice. Expression of the activation markers CD25 and CD69 did not differ from those of wild type mice. However, all thymocyte subsets from the TSP1-deficient mice exhibited consistent and significant reductions in cell surface level of CD44 relative to the same subsets from wild type mice. In the spleen, percentages of B cells, NK cells, macrophages, CD4+ and CD8+ T cells were also the same in TSP1 mutant and wild type mice, but all splenocyte subsets in TSP1 null mice displayed significantly decreased levels of CD44. CD44 mediates cell-cell and cell-matrix interaction in a large part through its affinity for the polysaccharide hyaluronan. TSP1 is not a direct ligand for CD44 or hyaluronan, but both interact with a number of other proteins. Some of these may also be TSP1 ligands. Future experiments will further characterize the mechanism for dysregulation of CD44 in TSP1 transgenic mice and the functional consequences of altered CD44 expression in the physiological functions of TSP1 and the immune pathology of TSP1 null mice.

Agency
National Institute of Health (NIH)
Institute
Division of Clinical Sciences - NCI (NCI)
Type
Intramural Research (Z01)
Project #
1Z01SC009174-01
Application #
7068856
Study Section
(LP)
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
2004
Total Cost
Indirect Cost
Name
Clinical Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
MacDonald, Christopher J; Cheng, Robert Y S; Roberts, David D et al. (2009) Modulation of carcinogen metabolism by nitric oxide-aspirin 2 is associated with suppression of DNA damage and DNA adduct formation. J Biol Chem 284:22099-107
Isenberg, Jeff S; Qin, Yan; Maxhimer, Justin B et al. (2009) Thrombospondin-1 and CD47 regulate blood pressure and cardiac responses to vasoactive stress. Matrix Biol 28:110-9
Ridnour, Lisa A; Thomas, Douglas D; Switzer, Christopher et al. (2008) Molecular mechanisms for discrete nitric oxide levels in cancer. Nitric Oxide 19:73-6
Isenberg, Jeff S; Frazier, William A; Krishna, Murali C et al. (2008) Enhancing cardiovascular dynamics by inhibition of thrombospondin-1/CD47 signaling. Curr Drug Targets 9:833-41
Kuznetsova, Svetlana A; Mahoney, David J; Martin-Manso, Gema et al. (2008) TSG-6 binds via its CUB_C domain to the cell-binding domain of fibronectin and increases fibronectin matrix assembly. Matrix Biol 27:201-10
Isenberg, J S; Frazier, W A; Roberts, D D (2008) Thrombospondin-1: a physiological regulator of nitric oxide signaling. Cell Mol Life Sci 65:728-42
Ptaszynska, Malgorzata M; Pendrak, Michael L; Bandle, Russell W et al. (2008) Positive feedback between vascular endothelial growth factor-A and autotaxin in ovarian cancer cells. Mol Cancer Res 6:352-63
Isenberg, Jeff S; Maxhimer, Justin B; Powers, Perlita et al. (2008) Treatment of liver ischemia-reperfusion injury by limiting thrombospondin-1/CD47 signaling. Surgery 144:752-61
Isenberg, Jeff S; Romeo, Martin J; Maxhimer, Justin B et al. (2008) Gene silencing of CD47 and antibody ligation of thrombospondin-1 enhance ischemic tissue survival in a porcine model: implications for human disease. Ann Surg 247:860-8
Roberts, D D (2008) Thrombospondins: from structure to therapeutics. Cell Mol Life Sci 65:669-71

Showing the most recent 10 out of 18 publications